Clinical implications of hereditary breast cancer.
Quan
May Lynn
ML
Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Petrek
Jeanne A
JA
D000328:Adult; D017668:Age of Onset; D000368:Aged; D019313:BRCA1 Protein / Q000235:genetics; D024682:BRCA2 Protein / Q000235:genetics; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics* / Q000628:therapy; D005260:Female; D005817:Genetic Counseling; D030342:Genetic Diseases, Inborn / Q000175:diagnosis / Q000453:epidemiology; D020022:Genetic Predisposition to Disease / Q000453:epidemiology*; D005820:Genetic Testing / Q000379:methods; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics*; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D015996:Survival Rate
D019313:BRCA1 Protein; D024682:BRCA2 Protein; D009363:Neoplasm Proteins